Gao Ben-Bo, Clermont Allen, Rook Susan, Fonda Stephanie J, Srinivasan Vivek J, Wojtkowski Maciej, Fujimoto James G, Avery Robert L, Arrigg Paul G, Bursell Sven-Erik, Aiello Lloyd Paul, Feener Edward P
Research Division, Joslin Diabetes Center, One Joslin Place, Harvard Medical School, Boston, Massachusetts 02215, USA.
Nat Med. 2007 Feb;13(2):181-8. doi: 10.1038/nm1534. Epub 2007 Jan 28.
Excessive retinal vascular permeability contributes to the pathogenesis of proliferative diabetic retinopathy and diabetic macular edema, leading causes of vision loss in working-age adults. Using mass spectroscopy-based proteomics, we detected 117 proteins in human vitreous and elevated levels of extracellular carbonic anhydrase-I (CA-I) in vitreous from individuals with diabetic retinopathy, suggesting that retinal hemorrhage and erythrocyte lysis contribute to the diabetic vitreous proteome. Intravitreous injection of CA-I in rats increased retinal vessel leakage and caused intraretinal edema. CA-I-induced alkalinization of vitreous increased kallikrein activity and its generation of factor XIIa, revealing a new pathway for contact system activation. CA-I-induced retinal edema was decreased by complement 1 inhibitor, neutralizing antibody to prekallikrein and bradykinin receptor antagonism. Subdural infusion of CA-I in rats induced cerebral vascular permeability, suggesting that extracellular CA-I could have broad relevance to neurovascular edema. Inhibition of extracellular CA-I and kallikrein-mediated innate inflammation could provide new therapeutic opportunities for the treatment of hemorrhage-induced retinal and cerebral edema.
视网膜血管通透性过高会导致增殖性糖尿病视网膜病变和糖尿病性黄斑水肿的发病,这是导致工作年龄成年人视力丧失的主要原因。通过基于质谱的蛋白质组学技术,我们在人玻璃体中检测到了117种蛋白质,并发现糖尿病视网膜病变患者玻璃体中细胞外碳酸酐酶-I(CA-I)水平升高,这表明视网膜出血和红细胞裂解对糖尿病玻璃体蛋白质组有影响。向大鼠玻璃体内注射CA-I会增加视网膜血管渗漏并导致视网膜内水肿。CA-I诱导的玻璃体碱化会增加激肽释放酶活性及其生成的因子XIIa,揭示了接触系统激活的一条新途径。补体1抑制剂、抗前激肽释放酶中和抗体和缓激肽受体拮抗剂可减轻CA-I诱导的视网膜水肿。向大鼠硬膜下输注CA-I会诱导脑血管通透性增加,这表明细胞外CA-I可能与神经血管水肿广泛相关。抑制细胞外CA-I和激肽释放酶介导的先天性炎症可为治疗出血性视网膜和脑水肿提供新的治疗机会。